Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STA-9090 (Ganetespib) in Refractory Metastatic Colorectal Cancer
NCT01111838Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ganetespib in colorectal cancer (CRC), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Overall Objective Response. Started Apr 2010; status: completed.
02
Drugs
ganetespib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01111838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01111838.